Asset Outperformer Engine (AOE) - Find Outperforming Assets
The Asset Outperformer Engine identifies assets that consistently outperform benchmark assets across multiple timeframes. Track relative strength across crypto, stocks, ETFs, precious metals, commodities, and mutual funds.
Benchmarks
All assets are compared against a customisable benchmark basket. The default basket is Bitcoin (BTC), Ethereum (ETH), Solana (SOL), gold (XAU/USD) and the S&P 500 (SPY); users can build their own basket from any benchmark or universe asset and choose which windows count.
Asset Categories
- Crypto: 3,000+ tokens by market cap
- Stocks: 400+ US equities (S&P 500, NASDAQ 100, sector leaders)
- ETFs & Index Funds: 130+ ETFs across sectors, bonds, and commodities
- Precious Metals: Gold, Silver, Platinum, Palladium
- Commodities: Oil, Natural Gas, Wheat, Corn, Copper, Uranium, Lithium
- Mutual Funds: 20+ index and managed funds
Scoring & Phases
Each asset receives a composite score (0-100) from its outperformance versus the benchmark basket: short term (1D and 7D), medium term (30D), long term (1Y) and consistency. Assets are classified into market phases: Phase A (early recovery), Phase B (confirmed uptrend), Phase C (strong outperformer), Accumulation (sideways), or Distribution (losing momentum).
Top Outperforming Assets
| Symbol | Name | Type | Price | Market Cap | Score | Phase | 30D |
|---|
| GLOB | Ossiam Global Perspectives UCITS ETF 1D (EUR) | Mutual fund | 108,878.62 EUR | 0.00 USD | 68 | Phase B | +8.82% |
| BITI | BetaPro Inverse Bitcoin ETF | Mutual fund | 20.43 USD | 73.17 M USD | 67 | Phase B | +15.49% |
| AMZE | Leverage Shares 2x Amazon ETP Securities | Mutual fund | 82.50 EUR | 0.00 USD | 59 | Phase B | +6.11% |
| AIE | Ashoka India Equity Investment Trust plc | Mutual fund | 2.70 GBP | 542.61 M USD | 58 | Phase B | +9.33% |
| INR | Amundi MSCI India Swap UCITS ETF USD Acc | Mutual fund | 27.68 EUR | 0.00 USD | 58 | Phase B | +11.88% |
| CARE | Bellevue Healthcare UCITS ETF | Mutual fund | 10.71 CHF | 0.00 USD | 57 | Phase B | +11.11% |